PUBLISHER: The Business Research Company | PRODUCT CODE: 1957449
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957449
mRNA Cancer Vaccines And Therapeutics Global Market Report 2026
mRNA cancer vaccines and therapeutics are a form of medical treatment that use messenger RNA (mRNA) to activate the immune system to detect and combat cancer cells. This approach works by delivering genetic instructions that enable cells to produce specific therapeutic proteins or enzymes, thereby training the immune system to recognize and eliminate cancer cells that display these antigens.
The primary types of mRNA cancer vaccines and therapeutics include adenocarcinomas, mucinous carcinomas, and adenosquamous carcinomas. Adenocarcinomas refer to a category of cancer that develops in mucus-producing glands across various parts of the body. These vaccines and therapeutics are applied in the treatment of infectious diseases, cancer, and other conditions, and are utilized by multiple end users such as hospitals and clinics, ambulatory surgical centers, research institutes, and others.
Tariffs have influenced the mRNA cancer vaccines and therapeutics market by increasing costs associated with importing specialized raw materials, lipid nanoparticles, and advanced biomanufacturing equipment. These impacts are most evident in regions reliant on cross-border supply chains, particularly North America and Europe. Higher costs have affected early-stage manufacturing and clinical-scale production timelines. However, tariffs have also encouraged local manufacturing investments and regional supply chain development to improve long-term resilience.
The mrna cancer vaccines and therapeutics market research report is one of a series of new reports from The Business Research Company that provides mrna cancer vaccines and therapeutics market statistics, including mrna cancer vaccines and therapeutics industry global market size, regional shares, competitors with a mrna cancer vaccines and therapeutics market share, detailed mrna cancer vaccines and therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the mrna cancer vaccines and therapeutics industry. This mrna cancer vaccines and therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mrna cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $71.22 billion in 2025 to $82.67 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to success of mrna platforms in infectious disease vaccines, advancements in cancer immunology research, increasing understanding of tumor antigens, early clinical validation of mrna cancer therapies, growing public and private funding for oncology innovation.
The mrna cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $141.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising global cancer burden, growing demand for personalized and targeted cancer treatments, expansion of mrna manufacturing capacity, increasing number of oncology clinical trials using mrna platforms, strategic collaborations between biotech and pharmaceutical companies. Major trends in the forecast period include rising adoption of personalized cancer vaccines, expansion of mrna-based therapeutics beyond oncology, growing focus on neoantigen-specific vaccine development, increased clinical pipeline for mrna cancer immunotherapies, higher investment in scalable mrna manufacturing platforms.
The increasing prevalence of cancer is anticipated to drive the expansion of the mRNA cancer vaccine and therapeutic market in the coming years. Cancer comprises a range of diseases marked by the uncontrolled growth and spread of abnormal cells that can invade and harm healthy tissues. The growing incidence of cancer is primarily linked to factors such as inactive lifestyles, unhealthy eating patterns, and exposure to environmental toxins, all of which raise the risk of developing different types of malignancies. mRNA cancer vaccines and therapeutics play a vital role in advancing cancer care by enabling personalized and targeted immune responses that assist the body in recognizing and destroying cancer cells more effectively, thereby enhancing treatment outcomes. For example, in January 2024, according to the American Cancer Society, Inc., a US-based cancer advocacy organization, the United States was projected to experience more than 611,000 cancer-related deaths in 2024, averaging over 1,600 deaths per day. Consequently, the rising prevalence of cancer is fueling the growth of the mRNA cancer vaccine and therapeutic market.
Major companies operating in the mRNA cancer vaccines and therapeutics market are concentrating on the development of advanced solutions, such as personalized neoantigen vaccines, to strengthen immune responses and improve survival outcomes for cancer patients. Personalized neoantigen vaccines are tailored cancer treatments created for individual patients by leveraging unique tumor-specific mutations to activate the immune system to recognize and eliminate cancer cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-driven biopharmaceutical company, collaborated with Moderna Therapeutics, Inc., a US-based biotechnology company, to launch a Phase 3 randomized clinical trial (V940-001) evaluating mRNA-4157 (V940) in combination with KEYTRUDA (pembrolizumab) as an adjuvant therapy for patients with resected high-risk (Stage IIB-IV) melanoma. This trial builds on encouraging results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, which demonstrated a significant benefit of the combination therapy compared with KEYTRUDA alone in lowering the risk of recurrence and distant metastasis. The Phase 3 study is designed to validate these outcomes by measuring relapse-free survival and distant metastasis-free survival as the primary and secondary endpoints, respectively.
In June 2025, BioNTech SE, a biotechnology company based in Germany, acquired CureVac N.V. for an undisclosed consideration. Through this acquisition, BioNTech SE seeks to enhance its capabilities across the research, development, manufacturing, and commercialization of mRNA-based cancer immunotherapy candidates, representing an important milestone in its oncology strategy to accelerate innovative cancer therapies and set new standards of care in the years ahead. CureVac N.V. is a Germany-based company engaged in the development of mRNA-based cancer vaccines and therapeutic solutions.
Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna cancer vaccines and therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the mrna cancer vaccines and therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
mRNA cancer vaccines and therapeutics market consists of sales of individualized cancer treatment mRNA vaccine, infectious disease treatment mRNA vaccine, and infection prevention mRNA vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
mRNA Cancer Vaccines And Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses mrna cancer vaccines and therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mrna cancer vaccines and therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mrna cancer vaccines and therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
- Markets Covered:1) By Type: Adeno Carcinomas; Mucinous Carcinomas; Adenosquamous Carcinomas
- 2) By Application: Cancer; Other Applications
- 3) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Research Institutes; Other End Users
- Subsegments:
- 1) By Adeno Carcinomas: Lung Adenocarcinomas; Colon Adenocarcinomas; Prostate Adenocarcinomas
- 2) By Mucinous Carcinomas: Mucinous Ovarian Cancer; Mucinous Breast Cancer; Mucinous Colorectal Cancer
- 3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma; Cervical Adenosquamous Carcinoma; Esophageal Adenosquamous Carcinoma
- Companies Mentioned: BioNTech SE; Moderna Therapeutics Inc.; CureVac N.V.; Arcturus Therapeutics Holdings Inc.; Immatics Biotechnologies GmbH; Argos Therapeutics Inc.; Anima Biotech; Translate Bio; eTheRNA Immunotherapies NV; Gritstone bio Inc.; Neon Therapeutics; Codiak BioSciences; Cartesian Therapeutics; Replimune Group Inc.; Precision BioSciences; Acuitas Therapeutics; Ethris GmbH; Strand Therapeutics; Crown Bioscience; Roche (Hoffmann-La Roche AG)
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: Word, PDF or Interactive Report
- + Excel Dashboard
- Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
Table of Contents
1. Executive Summary
- 1.1. Key Market Insights (2020-2035)
- 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
- 1.3. Major Factors Driving the Market
- 1.4. Top Three Trends Shaping the Market
2. mRNA Cancer Vaccines And Therapeutics Market Characteristics
- 2.1. Market Definition & Scope
- 2.2. Market Segmentations
- 2.3. Overview of Key Products and Services
- 2.4. Global mRNA Cancer Vaccines And Therapeutics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
- Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
- 2.4.4. Market Attractiveness Scoring and Interpretation
- 2.4.5. Strategic Implications and Recommendations
3. mRNA Cancer Vaccines And Therapeutics Market Supply Chain Analysis
- 3.1. Overview of the Supply Chain and Ecosystem
- 3.2. List Of Key Raw Materials, Resources & Suppliers
- 3.3. List Of Major Distributors and Channel Partners
- 3.4. List Of Major End Users
4. Global mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies
- 4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Sustainability, Climate Tech & Circular Economy
- 4.2. Major Trends
- 4.2.1 Rising Adoption Of Personalized Cancer Vaccines
- 4.2.2 Expansion Of Mrna-Based Therapeutics Beyond Oncology
- 4.2.3 Growing Focus On Neoantigen-Specific Vaccine Development
- 4.2.4 Increased Clinical Pipeline For Mrna Cancer Immunotherapies
- 4.2.5 Higher Investment In Scalable Mrna Manufacturing Platforms
5. mRNA Cancer Vaccines And Therapeutics Market Analysis Of End Use Industries
- 5.1 Hospitals And Clinics
- 5.2 Ambulatory Surgical Centers
- 5.3 Cancer Treatment Centers
- 5.4 Academic And Clinical Research Institutes
- 5.5 Biotechnology And Pharmaceutical Research Facilities
6. mRNA Cancer Vaccines And Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global mRNA Cancer Vaccines And Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
- 7.1. Global mRNA Cancer Vaccines And Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 7.2. Global mRNA Cancer Vaccines And Therapeutics Market Size, Comparisons And Growth Rate Analysis
- 7.3. Global mRNA Cancer Vaccines And Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
- 7.4. Global mRNA Cancer Vaccines And Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global mRNA Cancer Vaccines And Therapeutics Total Addressable Market (TAM) Analysis for the Market
- 8.1. Definition and Scope of Total Addressable Market (TAM)
- 8.2. Methodology and Assumptions
- 8.3. Global Total Addressable Market (TAM) Estimation
- 8.4. TAM vs. Current Market Size Analysis
- 8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. mRNA Cancer Vaccines And Therapeutics Market Segmentation
- 9.1. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
- 9.2. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Cancer, Other Applications
- 9.3. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
- 9.4. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adeno Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
- 9.5. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Mucinous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
- 9.6. Global mRNA Cancer Vaccines And Therapeutics Market, Sub-Segmentation Of Adenosquamous Carcinomas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
10. mRNA Cancer Vaccines And Therapeutics Market Regional And Country Analysis
- 10.1. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
- 10.2. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market
- 11.1. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China mRNA Cancer Vaccines And Therapeutics Market
- 12.1. China mRNA Cancer Vaccines And Therapeutics Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 12.2. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India mRNA Cancer Vaccines And Therapeutics Market
- 13.1. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan mRNA Cancer Vaccines And Therapeutics Market
- 14.1. Japan mRNA Cancer Vaccines And Therapeutics Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 14.2. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia mRNA Cancer Vaccines And Therapeutics Market
- 15.1. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia mRNA Cancer Vaccines And Therapeutics Market
- 16.1. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea mRNA Cancer Vaccines And Therapeutics Market
- 17.1. South Korea mRNA Cancer Vaccines And Therapeutics Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 17.2. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan mRNA Cancer Vaccines And Therapeutics Market
- 18.1. Taiwan mRNA Cancer Vaccines And Therapeutics Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 18.2. Taiwan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia mRNA Cancer Vaccines And Therapeutics Market
- 19.1. South East Asia mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 19.2. South East Asia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe mRNA Cancer Vaccines And Therapeutics Market
- 20.1. Western Europe mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 20.2. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK mRNA Cancer Vaccines And Therapeutics Market
- 21.1. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany mRNA Cancer Vaccines And Therapeutics Market
- 22.1. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France mRNA Cancer Vaccines And Therapeutics Market
- 23.1. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy mRNA Cancer Vaccines And Therapeutics Market
- 24.1. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain mRNA Cancer Vaccines And Therapeutics Market
- 25.1. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market
- 26.1. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 26.2. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia mRNA Cancer Vaccines And Therapeutics Market
- 27.1. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America mRNA Cancer Vaccines And Therapeutics Market
- 28.1. North America mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 28.2. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA mRNA Cancer Vaccines And Therapeutics Market
- 29.1. USA mRNA Cancer Vaccines And Therapeutics Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 29.2. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada mRNA Cancer Vaccines And Therapeutics Market
- 30.1. Canada mRNA Cancer Vaccines And Therapeutics Market Overview
- Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 30.2. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America mRNA Cancer Vaccines And Therapeutics Market
- 31.1. South America mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 31.2. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil mRNA Cancer Vaccines And Therapeutics Market
- 32.1. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East mRNA Cancer Vaccines And Therapeutics Market
- 33.1. Middle East mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 33.2. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa mRNA Cancer Vaccines And Therapeutics Market
- 34.1. Africa mRNA Cancer Vaccines And Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 34.2. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. mRNA Cancer Vaccines And Therapeutics Market Regulatory and Investment Landscape
36. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Company Profiles
- 36.1. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
- 36.2. mRNA Cancer Vaccines And Therapeutics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
- 36.3. mRNA Cancer Vaccines And Therapeutics Market Company Profiles
- 36.3.1. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Moderna Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. CureVac N.V. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Immatics Biotechnologies GmbH Overview, Products and Services, Strategy and Financial Analysis
37. mRNA Cancer Vaccines And Therapeutics Market Other Major And Innovative Companies
- Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)
38. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market
40. mRNA Cancer Vaccines And Therapeutics Market High Potential Countries, Segments and Strategies
- 40.1 mRNA Cancer Vaccines And Therapeutics Market In 2030 - Countries Offering Most New Opportunities
- 40.2 mRNA Cancer Vaccines And Therapeutics Market In 2030 - Segments Offering Most New Opportunities
- 40.3 mRNA Cancer Vaccines And Therapeutics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies
41. Appendix
- 41.1. Abbreviations
- 41.2. Currencies
- 41.3. Historic And Forecast Inflation Rates
- 41.4. Research Inquiries
- 41.5. The Business Research Company
- 41.6. Copyright And Disclaimer
